Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company engaged in the discovery development and commercialization of first-in-class therapies for the treatment of patients with AERI Aerie Pharmaceuticals — Stock Price and Discussion ... Real-time trade and investing ideas on Aerie Pharmaceuticals AERI from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, Aerie Pharmaceuticals, Inc. - AERI - Stock Price Today - Zacks
28 Feb 2020 The shares of Aerie Pharmaceuticals Inc. (NASDAQ:AERI) has been pegged with a That day the Citigroup set price target on the stock to $36.
Stock Information | Aerie Pharmaceuticals, Inc Aerie At-a-Glance; Our Leadership; Our Board of Directors; Our ESG Commitment; Products. Rhopressa ® Rocklatan ™ R&D. Pipeline. AR-13503 Implant; AR-1105 Implant; Drug Delivery; Clinical Trials; Research Bibliography; Investigator Initiated Research; For Eye Care Professionals. Our VISION aerie ™ Legacy Aqueous Humor Dynamics; Trabecular AERI:NASDAQ GM Stock Quote - Aerie Pharmaceuticals Inc ... Stock analysis for Aerie Pharmaceuticals Inc (AERI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AERI Price Target and Analyst Ratings (Aerie Pharmaceuticals) Nov 09, 2019 · 12 Wall Street analysts have issued ratings and price targets for Aerie Pharmaceuticals in the last 12 months. Their average twelve-month price target is $39.29, suggesting that the stock has a possible upside of 222.81%. The high price target for AERI is $56.00 and the low price … Aerie Pharmaceuticals, Inc. Common Stock (AERI) Real-Time ...
AERI: Aerie Pharmaceuticals, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Aerie Pharmaceuticals, Inc. from Zacks Investment Research
Historical daily share price chart and data for Aerie Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for Aerie Pharmaceuticals as of Stockopedia rates Aerie Pharmaceuticals Inc as a Adventurous Sucker Stock . 9 brokers rate it as a 'Buy'. Click to view NMQ:AERI's StockReport. 30 Mar 2020 Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and In depth view into AERI (Aerie Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.
View the real-time AERI price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aerie Pharmaceuticals against related stocks people have also bought like VKTX, ACB, CGC, and HEXO. 1,071 people own Aerie Pharmaceuticals on Robinhood on April 3, 2020.
Aerie Pharmaceuticals, Inc. Common Stock (AERI) Stock ... Aerie Pharmaceuticals, Inc. Common Stock (AERI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Aerie Pharmaceuticals, Inc. (AERI) Stock Price, Quote ... Find the latest Aerie Pharmaceuticals, Inc. (AERI) stock quote, history, news and other vital information to help you with your stock trading and investing. Aerie Pharmaceuticals - AERI - Stock Price & News | The ...
Learn about AERI with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar
AERI - Aerie Pharmaceuticals, Inc. - Stock Market Insights Aerie Pharmaceuticals, Inc. (AERI) latest earnings report: revenue, EPS, surprise, history, news and analysis. Aerie Pharmaceuticals Stock Quote. AERI - Stock Price ... Aerie Pharmaceuticals (AERI) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Aerie Pharmaceuticals - AERI - Stock Price & News | The ... Real time Aerie Pharmaceuticals (AERI) stock price quote, stock graph, news & analysis.
Aerie Pharmaceuticals stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.